The QualityStocks Daily Stock List
- MediPharm Labs Corp. (MEDIF)
- School Specialty, Inc. (SCOO)
- Seven Generations Energy Ltd. (SVRGF)
- The Tinley Beverage Company, Inc. (TNYBF)
- Advantage Lithium Corp. (AVLIF)
- Crop Infrastructure Corp. (CRXPF)
- Manganese X Energy Corp. (SNCGF)
- Relmada Therapeutics, Inc. (RLMD)
- IronClad Encryption Corporation (IRNC)
- Pura Naturals, Inc. (PNAT)
- Mikros Systems Corp. (MKRS)
- Ocean Thermal Energy Corporation (CPWR)
- GH Capital, Inc. (GHHC)
- Spotlight Innovation, Inc. (STLT)
MediPharm Labs Corp. (MEDIF)
Stock Day Media, Stock Sharks News, CannabisMarketCap, CannabisFN, Investing News, New Cannabis Ventures, Small Cap Power, Street Register, Stockwatch, OTC Markets, Stockhouse, Midas Letter, Micro Small Cap, InvestorsHub, Insider Financial, and Seeking Alpha reported beforehand on MediPharm Labs Corp. (MEDIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MediPharm Labs Corp. is an international leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation. It is the first company in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation licence. The Company chiefly focuses on producing pharma-grade cannabis oil and concentrates in Canada. Formed in 2015, MediPharm Labs has its head office in Barrie, Ontario. The Company lists on the OTC Markets’ OTCQX.
Fundamentally, MediPharm Labs is a global leader in premier quality, industrial-scale cannabinoid-based derivatives. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with 5 primary extraction lines having 300,000 KG of annual processing capacity to deliver pure, safe, and precisely-dosed cannabis products for its customers.
The Company’s private label program is a high margin business. It procures dry cannabis flower and trim from its manifold product supply partners to produce cannabis oil concentrate products for resale around the world on a private label basis. MediPharm Labs delivers pure, safe and precisely dosable cannabis concentrates for private label advanced derivative products.
MediPharm Labs also focuses on providing cannabis contract processing services to licensed producers and growers. Moreover, it concentrates on supplying cannabis oil to companies for sale under its brand; and supplying raw materials and processing for the creation of market ready cannabis products.
MediPharm has state-of-the-art technology and leading-edge proprietary methodologies. The Company is a leader in cannabis extraction and purification. It has highly scaled operations. Via its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia. It has completed commercial exports to Australia. Furthermore, it is nearing completion of its Australian extraction facility expected this year with 75,000 KG of annual processing capacity.
Last week, MediPharm Labs announced that its wholly-owned subsidiary, MediPharm Labs, Inc. closed a credit agreement with a top 5 Canadian Schedule 1 bank for an aggregate $38.7 million. The Credit Facility was upsized from the earlier announced committed term sheet of $20.0 million. It consists of a revolving term facility, a non-revolving term facility, and a non-revolving delayed draw term facility.
Pat McCutcheon, Chief Executive Officer of MediPharm Labs, said, “With the successful upsizing of our Credit Facility and the proceeds from our recent $75 million bought deal equity offering, we have strengthened our balance sheet and our ability to execute our global business plan to efficiently seize the growth opportunities before us. In particular, this enlarged facility will enhance liquidity and support the delivery of our stated Canadian and Australian capex strategy, to ramp up of production capacity to meet contracted and expected demand for our new product classes.”
MediPharm Labs Corp. (MEDIF), closed Tuesday's trading session at $3.1971, up 7.2852%, on 225,734 volume with 416 trades. The average volume for the last 3 months is 268,314 and the stock's 52-week low/high is $0.912500023/$5.65000009.
School Specialty, Inc. (SCOO)
NetworkNewsWire, Zacks, Last10k, Market Screener, MarketWatch, Capital Cube, Wallet Investor, GlobeNewswire, MarketBeat, Wallmine, TipRanks, Trading View, Simply Wall St, Stockhouse, Morningstar, and Stockopedia reported previously on School Specialty, Inc. (SCOO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
School Specialty, Inc. is a top provider of unique products and solutions that support integrated learning environments for improved student social, emotional, mental and physical well-being. The Company serves teachers, curriculum specialists, individual schools, school districts, parents, and administrators in varied healthcare related markets. Established in 1959, School Specialty is headquartered in Greenville, Wisconsin. The Company lists on the OTC Markets Group’s OTCQB.
School Specialty serves the United States and Canada through a comprehensive network of distribution centers powered by a multi-channel approach. The Company designs, develops, and delivers the broadest variety of innovative and proprietary products, programs, and services to the education marketplace. These include essential classroom supplies, furniture, educational technology, supplemental learning resources, science-based curriculum, and evidence-based safety training & security.
School Specialty offers its own proprietary products from best-in-class brands such as Sax, SSI Guardian, Frey, Foss and School Smart, and also some of the most trusted third-party brands in the educational marketplace. School Specialty has grown into a company that includes greater than 70 subject matter experts and other industry thought leaders always seeking out and sharing ground-breaking ideas to advance modern education.
Last week, School Specialty announced that its Board of Directors, in union with its legal and financial advisors, began a formal process to explore and evaluate potential strategic alternatives centered on maximizing shareholder value. School Specialty earlier disclosed that it has been working with a financial advisor to address its capital structure. It has expanded these efforts to include the review of a complete range of strategic and financing alternatives that may include a sale of the Company or other business combination. Its Board of Directors will carefully evaluate and consider all potential options. The Company noted that its Board will make a decision that reflects the best interest of all shareholders.
Mr. Gus Halas, Chairman of School Specialty, said, “School Specialty’s Board of Directors is fully committed to the evaluation and consideration of all potential strategic alternatives while we continue to support the Company’s employees in their important mission to deliver innovative products and solutions to our valued customers. We strongly believe that fully exploring multiple paths is in the best interest of our employees, suppliers, financial partners and shareholders.”
School Specialty, Inc. (SCOO), closed Tuesday's trading session at $2.05, up 7.8947%, on 11,100 volume with 5 trades. The average volume for the last 3 months is 4,481 and the stock's 52-week low/high is $1.62999999/$17.1000003.
Seven Generations Energy Ltd. (SVRGF)
Lamp News, TeleTrader, Street Insider, Wallmine, TradingView, 4-Traders, Stockwatch, Market Screener, GuruFocus, MarketBeat, Capital Cube, Nasdaq, Wallet Investor, Dividend Investor, Seeking Alpha, Morningstar, Stockhouse, and MarketWatch reported earlier on Seven Generations Energy Ltd. (SVRGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Seven Generations Energy Ltd. is an independent energy company listed on the OTC Markets. It concentrates on the development and value optimization of high-quality, tight-rock, natural gas resource plays. The Company is successfully developing its early-stage, multi-decade core development – the Kakwa River Project. Established in 2001, Seven Generations Energy has its corporate office in Calgary, Alberta.
The Company’s large-scale, liquids-rich Montney natural gas property encompasses greater than 500,000 net acres. It is situated approximately 100 kilometers south of its operations headquarters in Grande Prairie, in northwest Alberta. Seven Generations Energy employs long-reach horizontal drilling to produce low-supply cost resources of natural gas, condensate, as well as natural gas liquids (NGLs). The Montney is a geological formation covering 130,000 square kilometers. The formation contains trillions of cubic feet of recoverable natural gas, and billions of barrels of recoverable NGLs, condensate, as well as oil.
The Kakwa River Project is a high-quality property. It contains a large resource base considered sufficient to deliver a number of years of production growth at a supply cost that is among the lowest in North America. The Nest is Seven Generations Energy’s main development region. It can sustain between 15-20 years of future development drilling. The Company holds close to 100 percent interest in the Nest and in many surrounding areas.
The Nest is characterized by considerable NGLs and condensate. Seven Generations Energy’s assets are positioned within convenient reach of North America’s largest demand for condensate – the Canadian oil sands.
The Company has secured long-term marketing arrangements for its natural gas. It accomplished this through securing volumes on two transcontinental natural gas pipelines – Alliance and TransCanada – that intersect near Seven Generations Energy’s lands. Today, the Company has varied natural gas market access to markets in Alberta (AECO), Eastern Canada (Dawn), the US Mid-West (Chicago Citygate), the Gulf Coast (Henry Hub), and US West (Malin).
At the end of July 2019, Seven Generations Energy announced that it delivered $355 Million of Adjusted Funds Flow, $1.00 Per Share, and $44 Million of Free Cash Flow in Q2 Of 2019. Nest 3 Super Pad and gathering system connections were completed on time and budget such that Seven Generations Energy is positioned for a lower proportion of infrastructure spending in the balance of the year. It noted that it remains committed to its full-year capital guidance of $1.25 billion.
Seven Generations Energy Ltd. (SVRGF), closed Tuesday's trading session at $5.872, up 14.0194%, on 6,643 volume with 8 trades. The average volume for the last 3 months is 4,888 and the stock's 52-week low/high is $4.5472002/$11.9180498.
The Tinley Beverage Company, Inc. (TNYBF)
NetworkNewsWire, TipRanks, Beverage Start Up News, Wall Street Reporter, GuruFocus, Proactive Investors, OTC Markets, Cannabis Daily, Marijuana Stock Review, Market Screener, Pot Stock News, GlobeNewswire, Stockwatch, PR Newswire, Morningstar, Ceo.ca, Nasdaq, Daily Marijuana Observer, TradingView, InvestorsHub, Wallet Investor, Stockhouse, Seeking Alpha, and MarketWatch reported earlier on The Tinley Beverage Company, Inc. (TNYBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
The Tinley Beverage Company, Inc. created the Tinley™ Tonics and Tinley™ ‘27 line of cannabis beverages. In addition, the Company is building a 20,000 square foot cannabis beverage manufacturing and distribution facility in Long Beach, California. The Tinley Beverage Company’s shares trade on the OTC Markets Group’s OTCQX. The Company has its head office in Santa Monica, California.
The Tinley Beverage Company was established with a corporate mission to help consumers enjoy cannabis in familiar, classic beverages, Micro-Dosed to perfection. The Company’s multi-serve brand, Tinley™ ’27, pays respect to the year 2727 BC, which is the earliest recorded use of medical cannabis. Moreover, it is a nod to the year 1927. This is the year Prohibition ended in the Province of Ontario, Canada, from which some of the Company’s team members come from.
Non-Alcoholic Tinley™ Tonics and Tinley™ ’27 products are lower in sugar and calories than their beverage alcohol counterparts. The Company’s dedication is to excellence in formulation, sourcing, production, as well as distribution. It says that it has found the finest, fast-onset cannabis distillate from Northern California. The Tinley Beverage Company crafts it with premium essences of spirits and liqueurs, as well as terpenes for a full-flower effect.
Tinley has its ready-to-drink Tinley™ Tonics Stone Daisy™ and High Horse™. In addition, the Company has its multi-serve Tinley™ Elixirs, Coconut Cask, Cinnamon Cask, and Almond Cask.
Tinley™ Tonics ready-to-drink Stone Daisy™ Blue Agave Lime Tonic, and High Horse™ Spicy Ginger and Lime Tonic are non-alcoholic, single-serve versions of America’s favorite mixed drinks. They are crafted with natural flavors and lime essence. They are only 30 calories and contain 6g or less sugar per bottle. Furthermore, they have a Micro-Dose of premium Pineapple Jack sativa, for a fast-onset, full flower experience. Each 12 fl oz bottle equals one Micro-Dose serving.
The Tinley Beverage Company, Inc. (TNYBF), closed Tuesday's trading session at $0.33317, off by 7.4528%, on 110,397 volume with 41 trades. The average volume for the last 3 months is 23,082 and the stock's 52-week low/high is $0.294999986/$0.683099985.
Advantage Lithium Corp. (AVLIF)
The Bull Report, Streetwise Reports, The Prospector News, Gold Telegraph, Street Insider, Macroaxis, Market Wire News, Junior Mining Network, Mining News Feed, StockInvest.us, Market Screener, TipRanks, OTC Markets, Nasdaq, Morningstar, InvestorsHub, Investing News, Stockhouse, Wallet Investor, TradingView, Wallmine, GuruFocus, Investors Hangout, GlobeNewswire, and TMXmoney reported earlier on Advantage Lithium Corp. (AVLIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQX-listed, Advantage Lithium Corp. concentrates on developing its 75 percent owned Cauchari lithium project, located in Jujuy, Argentina (75 percent Advantage Lithium, 25 percent Orocobre Ltd.). In addition, the Company owns 100 percent interest in three additional lithium exploration properties in Argentina. These are Antofalla, Incahuasi, and Guayatayoc. Advantage Lithium has its corporate headquarters in Vancouver, British Columbia.
Fundamentally, Advantage Lithium is a lithium explorer and developer with top tier management and a global portfolio of quality assets. It has a partnership with Orocobre, one of Argentina’s top lithium producers, to develop its Cauchari asset. This asset hosts an inferred resource and includes a large exploration target. Orocobre is the largest single shareholder of Advantage Lithium.
The Cauchari Project encompasses approximately 28,000 hectares. It is less than 20km south of Orocobre’s producing Olaroz Plant. The Project is adjacent to an international highway, and has access to water and power. The Permitting process established with local governments is supportive. Orocobre is the only new lithium brine producer in the past 20 years. Greater than US $600M has been committed to developing the Cauchari-Olaroz basin in the past 12 months (as of May 2019).
This past July, Advantage Lithium confirmed positive progress with its Pre-Feasibility Study (PFS) on the Cauchari JV project in Argentina. The PFS remained on schedule for completion in early September with the release of the NI 43-101 Independent Technical Report within 45 days.
Following the successful 2018 drill campaign and considerable increase in contained mineral resource to 4.8Mt LCE in Measured and Indicated categories and 1.5Mt LCE in Inferred category, the PFS was commissioned in May of this year to measure the optimal production and processing profile to deliver maximum value from the expanded mineral resource. The PFS will include a mineral reserve, Opex and Capex within +/-25 percent accuracy, and financial analysis based on realistic and reasonable economic and engineering inputs.
In August, Orocobre Limited (ASX: ORE, TSX: ORL) agreed with Advantage Lithium to support a Private Placement by Advantage. Orocobre will participate in a C$1,703,100 Private Placement by Advantage at a price of C$0.41 per Common Share. The funds will be used by Advantage Lithium for general working capital and to fund ongoing development and exploration activities on its Lithium properties in Argentina. Moreover, subsequent to this, Advantage Lithium announced that it closed its earlier announced financing and issued 4,153,903 common shares for aggregate gross proceeds to Advantage Lithium of C$1,703,100 (the Private Placement).
Advantage Lithium Corp. (AVLIF), closed Tuesday's trading session at $0.19, up 30.0479%, on 43,887 volume with 18 trades. The average volume for the last 3 months is 32,116 and the stock's 52-week low/high is $0.142000004/$0.546564996.
CROP Infrastructure Corp. (CRXPF)
MicroSmallCap, StreetSignals, Investing News, Marijuana Stock Review, Wallet Investor, Stockhouse, TradingView, Proactive Investors, Pot Stock News, Daily Marijuana Observer, Morningstar, GlobeNewswire, Dividend Investor, Technical420, Stockwatch, Seeking Alpha, and InvestorX reported beforehand on CROP Infrastructure Corp. (CRXPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CROP Infrastructure Corp. centers on cannabis branding and real estate assets. Its portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space. The Company previously went by the name Fortify Resources, Inc. It changed its corporate name to CROP Infrastructure Corp. in March of 2018. Incorporated in 2011, CROP Infrastructure has its head office in Vancouver, British Columbia.
The Company focuses on the acquisition and ownership of a passive interest in specialized cannabis-related properties owned by different U.S. limited liability companies (each a US LLC). CROP Infrastructure deploys investment capital in an effort to maximize growth of income-producing U.S. State licensed cannabis producers and processors. To date, the Company’s investments have resulted in a considerable equity position in six US LLCs operating in California, Nevada, Oklahoma and Washington.
CROP Infrastructure has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands. It works to take advantage of strategic capital investment in land expansion opportunities; and assist with key big ticket investments, including greenhouses, foundations, roads, advanced hydroponics, electrical distribution networks, and specialized lighting systems. CROP is also working to develop relationships with approved agricultural plant input partners for uniformly safe fertilizers, nutrients, herbicides, and pesticides as an element of a bulk distribution service and inventive GROWSAFE-CROPSAFE client certification program.
Last week, CROP Infrastructure announced major management actions to remedy recent operational failures from its investments and implement improved reporting protocols throughout its structure. This includes its investments. Company Management is taking remedial action with a number of US LLC partners after ‘very disappointing’ performances.
Therefore, Company Management intends to work with its other cooperative stakeholders and partners to take immediate action to overhaul management of its non-productive investments. Furthermore, Management will renegotiate operating agreements to adopt additional reporting, internal controls and audit rights of the partners.
CROP Infrastructure Corp. (CRXPF), closed Tuesday's trading session at $0.0265, off by 11.6667%, on 813,759 volume with 78 trades. The average volume for the last 3 months is 300,596 and the stock's 52-week low/high is $0.012199999/$0.381000012.
Manganese X Energy Corp. (SNCGF)
Bull Market News, Geology for Investors, Investing News, Market Screener, InvestorIntel, Oil & Gas 360, The Prospector, Mining Stock Education, Ahead of the Herd, StreetWise Reports, Stockwatch, Wallet Investor, Stockhouse, and 4-Traders reported previously on Manganese X Energy Corp. (SNCGF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Manganese X Energy Corp.’s mission is to acquire and advance high potential manganese mining prospects in North America. Its intention is to supply value added materials to the lithium ion battery and other alternative energy industries. The Company formerly went by the name Sunset Cove Mining Inc. It changed its name to Manganese X Energy Corp. in December of 2016. Manganese X Energy is based in Saint-Laurent, Quebec, and the Company lists on the OTC Markets.
Manganese dioxide is a vital element in the manufacture of the most promising kinds of Lithium Ion batteries. These types of batteries are the most promising because of their superior storage capacity, safety, and cost. Manganese X Energy’s plan is to provide a secure ethically sourced manganese supply through exploring and developing its manganese rich deposit near Woodstock, New Brunswick (Battery Hill Project). The Battery Hill property consists of 55 claims totaling 1,228 hectares situated in Carlton County, New Brunswick. This project encompasses all or part of five manganese zones - Iron Ore Hill, Moody Hill, Sharpe Farm, Wakefield and Maple Hill.
In addition, Manganese X Energy has its Peter Lake Property. Peter Lake consists of 34 claims totalling roughly 1985 Ha located in the Mont-Laurier Terrane, in the Central Grenville Province, Quebec. Two Copper-Nickel-Cobalt Occurrences named Peter Lake North and Peter Lake South are included within this Property. Previous grab sampling returned values ranging from 0.4 percent to 22.8 percent copper, 0.14 percent to 0.73 percent nickel, 500 ppm to 0.266 percent cobalt, as well as elevated gold and silver.
The Peter Lake Property, around 20 kms south of Kintavar Exploration Inc.'s Mitchi Project, is where Kintavar announced significant new copper, silver, and gold mineralization. Manganese X Energy plans to conduct an exploration program on Peter Lake, with a complete compilation of historic geological work, followed by line cutting, ground geophysics, geology/prospecting, trenching and possible diamond drilling in the future. Special attention during the exploration program will be targeted at the cobalt and possible gold-platinum-palladium potential of the Property.
Manganese X Energy announced earlier in 2019 that a standalone subsidiary was created within the parent Company named Disruptive Battery Corp. The Company secured the domain batterydisruptors.com. The new company was created to hasten a manganese thesis as it relates to fuel cells and stored energy. The intention is to advance the movement of manganese for greener power production and penetrating the EV (Electric Vehicle) market.
Recently, Manganese X Energy presented its quarterly updated review of its projects, accomplishments and goals. On August 30, 2019, the Company signed a contract with Kemetco Research, Inc. to continue with the Ultra-Pure Metallurgical Project to produce high grade battery-eligible material for the North American li-ion and other alternative energy markets.
Additionally, its standalone subsidiary, Disruptive Battery, announced that it has been approached by, and is in discussions with, a Quebec entity to assist to develop and supply battery grade manganese materials for the North American lithium-ion battery (lib) market. Furthermore, regarding Mountain Springs Oil and Gas Limited (MSOG), Manganese X Energy has been advised by MSOG that they are in negotiations to finalize their initial Letter of Intent (LOI) for a specific oil and gas property package that is in Western Canada. Manganese X currently owns 15 percent of MSOG. It has an option of increasing ownership with an additional 10 percent interest, upon MSOG completing its present acquisition and with Manganese X Energy Board approval.
Concerning the Peter Lake Copper-Nickel-Cobalt Project (Quebec), the Company announced the completion of a MaxMin II-5 EM survey that began on September 15, 2019. Moreover, concerning the Lac Aux Bouleaux (LAB) Graphite Property (Quebec), Manganese X initiated a fall exploration program at the LAB Graphite property situated contiguous to the south of TIMCAL's Lac des Iles graphite mine.
Manganese X Energy Corp. (SNCGF), closed Tuesday's trading session at $0.0926, even for the day, on 600 volume. The average volume for the last 3 months is 551 and the stock's 52-week low/high is $0.062859997/$0.150000005.
Relmada Therapeutics, Inc. (RLMD)
NetworkNewsWire, OTC Markets, Wallet Investor, Capital Cube, Real Investment Advice, Zacks, Super Stock Screener, Simply Wall St, Market Screener, Equities, Trading View, Marketbeat, Street Insider, Stockhouse, Streetwise Reports, MarketWatch, and InvestorsHub reported previously on Relmada Therapeutics, Inc. (RLMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Relmada Therapeutics, Inc. is developing REL-1017 (dextromethadone) in manifold indications. RELM-1017 is in Phase 2 for treatment resistant depression and preclinical testing for additional indications. In essence, Relmada Therapeutics develops novel therapies for the treatment of central nervous system (CNS) diseases. A clinical-stage company, Relmada Therapeutics lists on the OTC Markets Group’s OTCQB. The Company is headquartered in New York, New York.
The expectation is that Relmada Thereapeutics’ approach will reduce clinical development risks and costs. This is while potentially delivering valuable products to address areas of high unmet medical needs.
The Company’s lead program is the above-mentioned dextromethadone (REL-1017). This is an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor antagonists may have potential in the treatment of a range of psychiatric and neurological disorders associated with an array of cognitive, neurological, as well as behavioral symptoms.
Relmada is targeting major advances in the treatment of CNS disorders. At present, REL-1017 is in a Phase 2a trial for the treatment of Major Depressive Disorder (MDD). Furthermore, there is considerable potential in numerous additional indications. This includes Rett Syndrome.
Relmada Therapeutics also has additional valuable pipeline assets for partnering. These include REL-1015 Levocap ER – a Phase 3-ready abuse deterrent formulation of a highly-potent opioid. Assets also include REL-1028 BuTab - an oral formulation of modified release buprenorphine for chronic pain. Additionally, assets include REL-1021 MepiGel – a novel topical version of local anesthetic mepivacaine for the treatment of painful peripheral neuropathies. Recently, Relmada Therapeutics announced that the last subject completed dosing with REL-1017 (dextromethadone) in the Company's double-blind, placebo-controlled Phase 2 clinical study evaluating the safety and efficacy of REL-1017 as an adjunctive treatment in patients affected by treatment-resistant depression. Relmada expects to announce topline results from the study in Q3 of 2019.
The Phase 2 study of REL-1017 in treatment resistant depression is a Phase 2, multicenter, randomized, double-blind, placebo-controlled 3-arm study. This study is to assess the safety and tolerability of multiple oral doses of REL-1017 25 mg and 50 mg as adjunctive therapy in the treatment of patients diagnosed with Major Depressive Disorder (MDD). Subjects in the study are adults with MDD who have experienced an inadequate response to one to three courses of treatment with an antidepressant medication. The study enrolled 62 subjects at approximately 10 sites in the U.S.
Relmada Therapeutics, Inc. (RLMD), closed Tuesday's trading session at $26.20, up 134.0289%, on 2,250,589 volume with 14,120 trades. The average volume for the last 3 months is 7,318 and the stock's 52-week low/high is $4.1999998/$36.00.
IronClad Encryption Corporation (IRNC)
4-Traders, PennyStockHub, The Street, Simply Wall St, MarketWatch, InvestorsHub, OTC Markets, YCharts, Barchart, Investors Hangout, Stock News Now and TradingView reported earlier on IronClad Encryption Corporation (IRNC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
IronClad Encryption Corporation is a next-generation cyber defense company headquartered in Houston, Texas. Its strategic and tactical data protection solutions strengthen existing encryption methods. The Company’s technology can provide continuous authentication of encrypted data transmitted, creating much stronger defenses to most hacker attacks. IronClad Encryption lists on the OTC Markets’ OTCQB.
IronClad Encryption-powered solutions use the Company’s patented Dynamic Encryption and Perpetual Authentication technologies to make all known key-based encryption technologies almost impossible to compromise. Dynamic Encryption Technology eliminates vulnerabilities caused by exposure of any single encryption key through continually changing encryption keys and keeping the keys synchronized in a fault-tolerant way.
Dynamic Encryption technology eliminates the single point of failure problem inherent in single-key encryption techniques. IronClad’s key management system continuously produces synchronous keys between the sender and receiver. Each key is assigned to a small amount of data. Therefore, if a hacker were to access one of hundreds of millions of keys, the amount of data he would obtain would be almost useless.
IronClad Encryption has a partnership with Black Pearl Engineering Management, Inc. to co-develop ultra-secure products based on IronClad’s patented ultra-secure cybersecurity algorithms and methodologies. The joint venture (JV) operates under the name "Black ICE". It is initially focusing on network gateway products. BlackICE Barrier is the first product in a family of BlackICE products. BlackICE Barrier is specifically targeted at enterprises and industrial use cases where data and control systems require the highest level of security.
IronClad Encryption offers its ICEMicro. This is the world’s first context-free and natively-secure container. It enables all developers to take ownership of application data security. Employing ICEMicro, any developer can secure communication between containers across varied scheduling and orchestration platforms, IaaS services, transport-layer security protocols, and on-premises or hybrid environments utilizing Docker-compatible hypervisors.
Recently, IronClad Encryption announced that it received notice from the United States Patent and Trademark Office (USPTO) that six of its patents were allowed. The titles of the IronClad patents that have been provided a Notice of Allowance include: Securitization of Temporal Digital Communications with Authentication and Validation of User and Access Devices; User-Wearable Secured Devices Provided Assuring Authentication and Validation of Data Storage and Transmission; and Devices that Utilize Random Tokens Which Direct Dynamic Random Access.
Titles also include: Devices for Transmitting and Communicating Randomized Encrypted Data Utilizing Sub-Channels; Executable Coded Cipher Keys; and Combined Hidden Dynamic Random-Access Devices Utilizing Selectable Keys and Key Locators for Communicating Randomized Data together with Sub-Channels and Coded Encryption Keys.
IronClad Encryption Corporation (IRNC), closed Tuesday's trading session at $0.0032, up 77.7778%, on 44,254,322 volume with 258 trades. The average volume for the last 3 months is 3,153,812 and the stock's 52-week low/high is $0.001399999/$0.449999988.
Pura Naturals, Inc. (PNAT)
Stockwatch, Clay Trader, Insider Financial, Marketwired, OTC Markets, WhaleWisdon, YCharts, Spotlight Growth, Tip Ranks, Dividend Investor, and MarketWatch reported on Pura Naturals, Inc. (PNAT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Pura Naturals, Inc. is working to deliver a purer clean by way of its innovative BeBetter Foam®. The Company is the manufacturer of unique foam cleaning products for the home. It has its proprietary foam technology, which absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. Pura Naturals is based in Lake Forest, California.
The Company focuses on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.
Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Pura Naturals’ household cleaning products deliver a unique soap infusion. The ground-breaking foam absorbs grease while repelling water and inhibiting bacteria growth and odors.
Pura Naturals also has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA). Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.
The Pura Marine division centers on developing solutions employing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors. Additionally, Pura Naturals has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner.
Pura also has its new line of health and beauty products. These products will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils.
Recently, Pura Naturals announced that the Grease Beast products went live on HomeDepot.com. Mr. Robert Doherty, Chief Executive officer of Pura Naturals, stated on December 12, 2018, "We have been live on HomeDepot.com for only a few days, and orders are flowing. This is a solid moment for Pura Naturals. Given the talent we have brought into the Company and the breadth of the achievements thus far, we expect a very strong 2019 for the Grease Beast product line."
Pura Naturals, Inc. (PNAT), closed Tuesday's trading session at $0.0004, even for the day, on 14,352,100 volume with 24 trades. The average volume for the last 3 months is 9,416,836 and the stock's 52-week low/high is $0.000399999/$0.010099999.
Mikros Systems Corp. (MKRS)
Promotion Stock Secrets, Addictive Penny Stocks, Chatter Box Stocks, StockLockandLoad, Stock Bomb, ResearchOTC, OTPicks, Penny Stock Rumors, OTCEquity, PennyStocks24, Awesome Stocks, Wall Street Mover, Priceless Penny Stocks, Stock Rock and Roll, Fast Money Alerts, Actual Gains, and Marketbeat reported on Mikros Systems Corp. (MKRS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Mikros Systems Corp. is a provider of advanced maintenance and monitoring solutions for mission-critical systems. The Company is an advanced technology enterprise that designs and manufactures specialized electronic systems for the Department of Defense. Its primary business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. Mikros Systems is based in Princeton, New Jersey. It has its Manufacturing and Depot Center in Largo, Florida.
The Company’s capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering. Mikros produces advanced maintenance systems for the Navy. These include the ADEPT Maintenance Automation Workstation and the ADSSS Condition Based Maintenance system for the Littoral Combat Ship. ADEPT systems are in use daily for performance optimization of advanced radar systems.
Mikros Systems’ Lifecycle Support capability is centered on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to attain the highest levels of system readiness. Mikros purchased certain software products, intellectual property (IP), and related assets from VSE Corp. The chief software programs purchased by Mikros Systems are the Diagnostic Profiler (DP) and Prognostics Framework (PF) programs.
Prognostics Framework is used by the U.S. Army for manifold missile defense systems. These software products provide Mikros Systems with the opportunity to service commercial customers and additional Department of Defense customers outside the Navy.
The Diagnostic Profiler software is used around the world by numerous multinational companies for optimized maintenance of diverse product lines. In addition, Diagnostic Profiler is used by the U.S. Air Force for depot test programs.
Recently, Mikros Systems announced that it received additional funding of $1.6 million to provide engineering, technical and logistics support for its ADEPT® (Adaptive Diagnostic Electronic Portable Testset) maintenance workstation product. Year-to-date, the Company has received more than $3.9 million in U.S. Navy funding to support production, engineering, and also technical support of the ADEPT product line.
Mikros Systems also recently announced financial results for the three and nine months ended September 30, 2018. Revenues for the three and nine months ended September 30, 2018 were $1,893,945 and $6,662,716, respectively. This is in comparison to $1,551,620 and $5,047,456 for the three months and nine months ended September 30, 2018, respectively.
This represents an increase of $342,325, or 22 percent for Q3, and an increase of $1,579,260, or 31 percent year-to date. These increases were due mainly to increased production of ADEPT® Units and additional engineering, calibration and support services.
Mikros Systems Corp. (MKRS), closed Tuesday's trading session at $0.14995, up 23.4664%, on 165,857 volume with 44 trades. The average volume for the last 3 months is 32,146 and the stock's 52-week low/high is $0.100100003/$0.479999989.
Ocean Thermal Energy Corporation (CPWR)
InvestorsHub, MarketWatch, YCharts, 4-Traders, Insider Monkey, Tidal Energy Today, Stockhouse, OTC Markets, Barchart, Investopedia, Marketbeat, and Simply Wall St reported earlier on Ocean Thermal Energy Corporation (CPWR), and today we choose to report the Company, here at the QualityStocks Daily Newsletter.
Ocean Thermal Energy Corporation constructs and operates clean hydrothermal energy plants around the word. The Company is a project developer for Ocean Thermal Energy Conversion (OTEC) plants that create renewable energy. It designs and develops deep-water hydrothermal clean-energy systems, which produce fossil-fuel free electricity through OTEC and environmentally friendly cooling through Seawater Air Conditioning (SWAC). OTCQB-listed, Ocean Thermal Energy is headquartered in Lancaster, Pennsylvania.
Seawater Air Conditioning (SWAC) technology generates air conditioning without the use of chemical agents. Acting alone, SWAC can reduce electricity usage by up to 90 percent in comparison to traditional air conditioning systems. When developed in association with OTEC plants, SWAC operates entirely without the use of fossil fuels.
OTEC leverages the temperature difference in the ocean between cold deep water and warm surface water in the tropics and subtropics to generate unlimited energy without the use of fossil fuels. In a closed cycle OTEC system, water flows through a large pipe and heat exchanger that heats a liquid with a low boiling point, such as ammonia. As the boiling ammonia produces steam, it turns a turbine generator to generate electricity.
A second pipe extracts cool deep water from the ocean that condenses the steam back to liquid form. As the ammonia is recycled, the process repeats, creating unlimited clean energy, 24 hours a day, 365 days a year (The Rankine Cycle). OTEC uses the solar energy from the ocean. No fossil fuels are used.
Ocean Thermal Energy has made significant progress on the development of its first OTEC EcoVillage. The Company has advanced toward the development of a SWAC system for the U.S. Military. The OTEC EcoVillage project comprises, in part, of an OTEC plant that will provide all power and water to approximately 400 residences. Additionally, it consists of a hotel, and shopping center, and models of sustainable agriculture, food production, and other economic developments.
Concerning the OTEC EcoVillage, the U.S. Virgin Islands’ Public Service Commission granted Ocean Thermal Energy regulatory approval for an OTEC plant. OTEC EcoVillage will be the first development in the world offering a net-zero carbon footprint.
Recently, Ocean Thermal Energy announced that it signed a Letter of Intent (LOI) to acquire an established, profitable, and experienced company in the heavy-commercial air conditioning business. The acquired company would bring considerable heavy-commercial air conditioning expertise and strong operational synergies. Furthermore, in August, Ocean Thermal Energy announced the appointment of three new members to its advisory board. These are Eric Moser, Founder and President of Moser Design Group; Julia Sanford, Founding Principal of Starr Stanford Design Associates; and Steve Mouzon, Principal at Mouzon Design.
Ocean Thermal Energy Corporation (CPWR), closed Tuesday's trading session at $0.0398, up 58.5657%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 9,298 and the stock's 52-week low/high is $0.024599999/$0.149900004.
GH Capital, Inc. (GHHC)
Penny Picks, OTC Markets, MarketWatch, Barchart, Stockopedia, Morningstar, and InvestorsHub reported on GH Capital, Inc. (GHHC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
GH Capital, Inc. has developed an online payment gateway (ClickDirectPay) to process online wire transfer transactions for different online merchants, chiefly in Europe. GH Capital is a FinTech holding company and offers a going public process advisory. Formed in 2014, GH Capital has its head office in Miami, Florida. The Company lists OTC Markets’ OTCQB.
GH Capital’s Financial Technology (FinTech) product is ClickDirectPay.com. Customers using ClickDirectPay can do a bank transfer fast, easily, as well as securely with their personal online banking information. Upon using ClickDirectPay, the merchant receives a real time transaction confirmation pertaining to the successful bank transfer.
GH Capital’s goal is to expand with ClickDirectPay worldwide. To meet this objective, it is working on concepts of Blockchain and Cryptocurrency processing.
Regarding the Company’s Capital Market Advisory Service, it guides and assists international companies from the U.S, Canada, Europe, and Asia to complete the whole going public process from the beginning. GH Capital’s mission is to help small and emerging growth companies to get through the complete IPO (Initial Public Offering) process without difficulties.
GH Capital is also considering acquisitions. The Company stated that 2018 could also be a year of acquiring companies from the payment industry. This could speed up the process to establish ClickDirectPay as a one stop solution for Cryptocurrency processing.
Recently, GH Capital announced that its online payment service subsidiary, ClickDirectPay, announced the launch of ClickDirectPay's Express Coin Payments. This provides merchants the ability to accept many cryptocurrencies into a secure wallet.
GH Capital also recently announced that its online payment service subsidiary, ClickDirectPay expanded its cryptocurrency payment solution offerings to support Monero, Dash, Zcash and Verge. The addition of these coins brings the total support of ClickDirectPay to 8 cryptocurrencies enabling businesses to scale their reach in accepting payments in the world of cryptocurrencies.
ClickDirectPay is introducing new tools for merchants to easily start accepting cryptocurrencies. In June, the Company announced that its online payment service subsidiary, ClickDirectPay rolled-out new tools to its online merchants to be able to more easily and quickly accept cryptocurrency as payment.
GH Capital, Inc. (GHHC), closed Tuesday's trading session at $0.0029, up 45.00%, on 28,124,779 volume with 222 trades. The average volume for the last 3 months is 8,869,861 and the stock's 52-week low/high is $0.001395/$0.043999999.
Spotlight Innovation, Inc. (STLT)
Penny Picks, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Beacon Equity Research, SuperStockTips, InvestorSoup, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Penny Stock Finder, Stock Preacher, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. The Company identifies and acquires rights to unique and proprietary platform technology candidates. Its emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities.
The Company’s subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. Spotlight Innovation is based in Urbandale, Iowa.
Spotlight Innovation’s mission is to considerably impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates’ is attained through its extensive relationships with numerous leading academic institutions and other sources. Spotlight provides value-added development capability and funding to expedite development progress.
The Company’s development pipeline includes product candidates for cancer, chronic pain, spinal muscular atrophy (SMA) and Zika virus infection. Spotlight works to acquire the rights, via acquisition, license, or otherwise, to innovative and proprietary Platform Technology Candidates. Additionally, it works to provide value-added development capability and funding to achieve fast IND approval to commence human clinicals for targeted Platform Technology Candidates.
Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive global rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.
Spotlight Innovation subsidiary Caretta Therapeutics has its chronic pain relief product Venodol Roll-on. This product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation.
Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. Its subsidiary, Celtic Biotech, started Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. Contract Research Organization (CRO) ImmunoClin Ltd. is supervising the study conduct.
Spotlight Innovation has entered into a multi-year partnership agreement with Hip-Hope, Inc. (Des Moines, Iowa-based), an organization committed to using arts and culture to promote, advocate and support hope for at-risk youth wherever symptoms of hopelessness are widespread.
As part of this partnership, Spotlight Innovation is the title sponsor for Hip-Hope’s 2018 “#kidslivesmatter FUNraiser Challenge” to take place August 3, 2018, at the 7 Flags Event Center in Clive, Iowa. The annual event is a youth empowerment campaign. The design of it is to build kids’ character, physical health, as well as self-esteem.
Recently, Spotlight Innovation announced that Company research collaborator Professor Kevin Hodgetts was awarded a grant of $300,000 by the nonprofit organization Cure SMA for the project Pre-Clinical Development of LDN-5178 for the Treatment of SMA.
Spotlight Innovation holds an exclusive, worldwide development and commercialization license from Indiana University Innovation and Commercialization Office for LDN-5178 and a group of related compounds. This includes STL-182.
Spotlight Innovation, Inc. (STLT), closed Tuesday's trading session at $0.008, up 25.00%, on 999 volume with 1 trade. The average volume for the last 3 months is 2,473 and the stock's 52-week low/high is $0.002/$0.035.
The QualityStocks Company Corner
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- B2Digital Inc. (OTC: BTDG)
- CloudCommerce (OTCQB: CLWD)
- Geyser Brands Inc. (TSX.V: GYSR)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Sharing Services Global Corporation (SHRG)
- Willow Biosciences Inc. (CSE: WLLW)
- SRAX Inc. (NASDAQ: SRAX)
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
- Sugarmade, Inc. (SGMD)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Trxade Group Inc. (TRXD)
- Xalles Holdings Inc. (OTC: XALL)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today in a publication from Financialnewsmedia.com, examining how, over the next three days, Canada will legalize CBD all over again. Just a year after legalizing dried cannabis flower, oils, and sprays, Canada will now legalize edibles, beverages, and topicals this Thursday, October 17, potentially creating sizable opportunity for growth.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Tuesday's trading session at $3.54, up 8.589%, on 2,833,890 volume with 8,810 trades. The average volume for the last 3 months is 1,265,184 and the stock's 52-week low/high is $2.71000003/$8.43999958.
- Cannabis 2.0: Canada Set to Legalize CBD Topicals and Beverages October 17, 2019
- Why the World of Fashion Should Turn to Hemp
- CBD Oil Social Event Hosted in Birmingham
B2Digital Inc. (OTC: BTDG)
B2Digital (OTC: BTDG) today announced that it is now fully reporting with the U.S. Securities and Exchange Commission (“SEC”) after filing a Form 8-A Registration Statement on October 9, 2019. As a result, B2Digital is now subject to the reporting requirements of the Exchange Act of 1934, as amended, including Form 10-K, Form 10-Q and Form 8-K reporting obligations, in addition to other reporting requirements associated with proxies, shareholder actions and stock ownership. To view the full press release, visit http://nnw.fm/jTy7a.
B2Digital Inc. (OTC: BTDG) is applying its extensive background in entertainment, television, video and technology to become a full-service live event sports company. Capitalizing on its strong management team, industry relationship, and hands-on experience in the industry, B2Digital is developing and acquiring Mixed Martial Arts (MMA) and sports-related companies to build an integrated premier development league initially for the billion-dollar MMA marketplace.
B2Digital’s management team boasts over 30 years of combined global experience developing more than 20 companies within the sports, television, entertainment, digital distribution and banking transaction industries.
Since its restructuring in 2017, the company is now forging ahead with company chairman and CEO Greg P. Bell at the helm. His expertise, relationships and experience bring a background of more than 40,000 successful live events throughout his career. Under his guidance, B2Digital will create and develop the “Development League” champions that will move on to the MMA major leagues from within the B2 Fighting Series.
In preparation, B2Digital has produced and applied the systems and technologies required to support and maintain infrastructural operations of the company, including: social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems. The company has also launched its B2 Social Media Network as the digital distribution system for the B2 Fighting Series.
As part of its growth strategy, B2Digital intends to continue to develop and acquire assets that meet its business model with the goal of becoming a premier vertically integrated live event sports company. In 2017, B2Digital started operating B2 Fighting Series, live MMA events; each year, the top fighters are invited to the live annual B2 Fighting Series National Championship.
B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks and branding for the B2Digital companies. The company has deployed its B2 Social Media Network digital distribution network for the B2 Fighting Series and has developed and deployed the systems and technologies for the operation of social media marketing, event engagement, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems.
Fight Groups (holdings)
- Colosseum Combat
- United Combat League
- Pinnacle Combat
- Bluegrass MMA
B2 Social Media Network (B2SN)
The B2 Social Media Network (B2SN) provides the connection between the B2Digital live events and the consumer audience by:
- Providing social interaction between consumers regarding B2Digital Properties and current relevant topics to the live events audience
- Offering “FTV” free-to-view live and on-demand TV style broadcasts globally of B2 Digital live events
- Promoting upcoming live events
- Selling tickets to B2 live events electronically
- Promoting the fighters, athletes and participants in the B2Digital live events
Chairman and CEO Greg P. Bell
Greg P. Bell is one of the early pioneers and entrepreneurs in entertainment and digital media and has been working in the field for over 30 years. He was involved in the early creation of the technologies and algorithms that allowed analog media to be transformed into digital bits and compressed data streams and created specific business enterprises that capitalized on the creation of digital transmissions at Scientific Atlanta, Compressions Labs, VCON International and Qwest. Bell was one of the initial vice presidents of business development at Qwest Communications where he developed Qwest’s digital media company, Slingshot Networks. He then ran all operations of Slingshot, reporting to the board of directors, which managed and operated three full time studios including the creation of the broadcast studio in Staples Center, TV and news productions, live events at the Staples Center, distribution of a national television show distributed by Warner Brothers TV Distribution, online television productions and web distribution for the NFL, AFL, NBA, NHL, Boxing, Democratic Convention and live music events.
Upon leaving Slingshot in 2000, Bell founded B3 Development Group, a firm specializing in developing emerging market entertainment and media companies. Bell’s B3 Development Group founded B2 Networks in 2001 which quickly became the defacto standard for watching live PPV sporting events online. B2’s proprietary online system broadcasts live professional and collegiate sporting events online to a global audience, broadcasting over 1,000 live games per month. Bell developed and implemented a merger with B2 Networks and the America ONE Television Network where he became CEO of the combined companies. Under Bell’s direction the company, now called ONE Media Corp., launched the new ONE World Sports TV Network in North America on cable and satellite, with a pure digital end-to-end distribution system, along with continuing the company’s growth in the online distribution of sports and entertainment.
After leaving as CEO of ONE Media Corp., he currently sits as chairman of B3 Development Group, which specializes in developing and fast-tracking emerging entertainment, transaction technology and media distribution companies. Bell continues to expand his holdings and currently has business holdings in ONE Media Corp; B3 Development Gaming Group which under contract with Caymanas Park Race Track, owned by the country of Jamaica, developed Jamaica’s first all-digital state of the art pari-mutuel live sports gaming system for mobile devices and currently is operating under the brand CaymanasToGO for the Caribbean Consumers and is licensed for deployment in the USA to USA-based consumers. The B3 Gaming Group mobile device wagering system and technology allows consumers globally to watch and wager on live horse races and sporting events being held in the UK, USA, Canada and the Caribbean; B3 Gaming Services Group, a premier transaction and customer service group that offers management services to the Gaming industry in the Caribbean, B3 Networks, a premier state of the art digital broadcasting company that developed the B3 television satellite replacement technology which allows TV networks to broadcast globally on the public internet instead of satellites in broadcast quality HD & SD television. B3 Networks has deployed, and services, the B3 technology to broadcast high definition TV signals globally to cable head ends, smart phones and internet connected devices for the Jamaica Education Television Network, the Caymanas Race Track and other mobile applications globally.
Bell has worked at the top technology development companies that developed the digital technologies, which are in use today at Scientific Atlanta, Compression Labs, VCON and Qwest. He also has managed and been directly involved with over 55,000 live events in his 30-year career. He has worked with a diverse group of clients in the entertainment, sports and technology communities including the NFL, NBA, NHL, AHL, NLL, ECHL, IFL, USHL, SPHL, NCAA, NAIA, MISL, AFL, AOL, FOX, UFC, NAAFS, Bellator, WEF, the Staples Center, the Orleans Arena, Oscar De La Hoya, Barbra Streisand, and top entertainment venues, acts and actors. His clients and companies have capitalized on Bell’s knowledge of the world of entertainment, live events, sports, digital television and digital online transaction and distribution systems.
B2Digital Inc. (BTDG), closed Tuesday's trading session at $0.0071, up 10.9375%, on 2,300,500 volume with 15 trades. The average volume for the last 3 months is 195,700 and the stock's 52-week low/high is $0.0023/$0.039999999.
- B2Digital, Inc. (BTDG) Becomes Fully Reporting with the SEC
- B2Digital (OTC: BTDG) B2 Social Media Network Surpasses 3.9M Connections in Q2 2019
- B2Digital Inc.’s (BTDG) B2 Fighting Series Continues with Pinnacle Combat Event, HRMMA CEO Receives Lifetime Achievement Award
CloudCommerce (OTCQB: CLWD)
CloudCommerce, Inc. (CLWD), a leading provider of audience-driven business intelligence and digital marketing solutions, today announced that it signed an extensive marketing services agreement with Starr Insurance Companies (“Starr”), one of the world’s fastest-growing insurance providers. Also today, NetworkNewsWire released a report highlighting the company which examines the recent news that CLWD ready to take on enterprise clients. That’s the message from CEO and President Andrew Van Noy. In a recent NetworkNewsAudio (NNA) interview with Stuart Smith of NetworkNewsWire, Van Noy discussed the company’s achievements to date and its strategy going forward (http://nnw.fm/Ik6Vo ).
CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.
SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.
Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.
Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.
However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.
In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.
THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.
BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.
HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.
HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.
Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.
Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.
Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.
Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.
Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.
CloudCommerce (OTCQB: CLWD), closed Tuesday's trading session at $0.003, off by 6.25%, on 565,944 volume with 10 trades. The average volume for the last 3 months is 1,039,469 and the stock's 52-week low/high is $0.0027/$0.0228.
- CloudCommerce Signs Agreement with Starr Insurance Companies
- CloudCommerce Inc. (CLWD) Ready to Target Enterprise Clients
- CloudCommerce Inc. (CLWD) Employs Behavioral-Science Approach to Identify Custom Audiences
Geyser Brands Inc. (TSX.V: GYSR)
A newly launched luxury hemp-based product line positions Geyser Brands Inc. (TSX.V: GYSR) as a leader in the cannabis wellness market. STōND is a line of 100-percent natural self-care products formulated with cannabis sativa hemp oil and features a wide range of products such as massage oils, body lotions, body scrubs, lip balms, mud masks, headache roll-ons, pain gels, joint creams, solid face serums and anti-wrinkle serums. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. In some California school districts, parents can now bring medical marijuana to their children in K-12 campuses; this is according to a new bill signed into law by Governor Gavin Newson. Last year, Governor Jerry Brown had barred the same bill.
Geyser Brands Inc. (TSX.V: GYSR) is a consumer wellness brand cultivator that builds and markets hemp-infused health and wellness products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, baked goods and tincture formulations with superior bioavailability and water solubility. Geyser Brands is rapidly building its revenue-generating operation with a marked milestone in September 2019 with the successful acquisition of Solace Management, a company whose portfolio includes 57 SKUs of consumer wellness goods and pet care products.
Solace recently moved into its new 7,500-square-foot GMP (Good Manufacturing Practices)-compliant facility in Coquitlam, British Columbia, which is expected to trigger up to a 10-fold increase in the company’s production capacity now that it has a Natural Health Product site license from Health Canada. Solace intends to also develop and license new products that are either ready for production or are in various stages of development, since construction of the facility is now complete.
Geyser Brands and Solace welcomed yet another marketable product to their stable with the receipt of an NPN (Natural Product Number) from Health Canada for their hemp-based pain relief roll-on, which means the pain-relief product can now be sold as a natural health product through the company’s Apothecary Naturals line. Health Canada assessed the roll-on and found it to be safe, effective and of high quality when it is used as directed.
The efficacy of most hemp products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; and provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company’s cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands’ integrated production chain and formulation lab develops innovative products using high-quality hemp for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands actively explores opportunities to invest in the research and development of unique, high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
- Apawthecary Pets – line of products has established itself as leading all-natural hemp-based pet treats with formulations for pet treats, salves and oral drops. Animals, like humans, may suffer from the insomnia, digestive difficulties, pain and inflammation hemp products are designed to relieve a wide variety of conditions. All of Apothecary’s products are made with organic, cold-pressed and unrefined hemp seed oil extract.
- Apothecary Naturals – 100% all-natural, organic, hemp-based topical products for everything from skin care to pain relief.
- WildTails – 100% all-natural, freeze-dried, single-ingredient and nano-hemp infused pet foods and treats.
- Apothecary Ink – Antibacterial skin preparation products, pain control as well as skin care for new and old tattoos.
Chairman and Co-Founder, Brad Kersch, brings a strong business background with over 20 years of experience in successful startups and working with Fortune 500 companies. He spent his early years in the advertising and marketing field and went on to form Hyperware, a clothing company that sold branded clothing to retailers across Canada before selling to clothing giant Ocean Pacific (OP). Kersch became the president of Shoreline Studios, Canada’s largest and oldest studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets.
CEO and Co-Founder, Andreas Thatcher, has been CEO of Geyser Brands since the January 2018 and has been a principal at Rhizome Group since 2014, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media investment company specializing in marketing and distribution financing, and worked in the Investment Banking industry in London and Toronto. Thatcher holds a master’s degree in economics.
CFO Gordon Clissold is a Chartered Professional Accountant with over 20 years of experience as an operational and financial manager for both public and private companies. His career experience spans multiple industries that include technology, manufacturing, wholesale distribution, and professional services. Gordon obtained his accounting designation in 1995, was awarded the Fellowship designation in 2006, and has been awarded life membership as Chartered Professional Accountant.
Kuldip Gill, head of Geyser Brands’ R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill’s experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Tuesday's trading session at $0.38, even for the day, on 2,315 volume. The average volume for the last 3 months is 2,200 and the stock's 52-week low/high is $0.349999994/$0.850000023.
- Geyser Brands Inc. (TSX.V: GYSR) Launches a New, All-Natural Luxury Product Line
- 420 with CNW – California Governor Signs Law Allowing Medical Marijuana on K-12 Campuses
- University of Wyoming Releases Hemp Publication
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 before an audience of well-vetted public and private companies, and an audience of fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market. Investment opportunities abound.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Tuesday's trading session at $2.2976, up 3.0314%, on 26,148 volume with 67 trades. The average volume for the last 3 months is 36,566 and the stock's 52-week low/high is $2.17000007/$6.00810003.
- Plus Products Inc. Presenting at the Benzinga Cannabis Capital Conference in Chicago
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Partners with John Legend, Casper Sleep for Nationwide Launch of CBD-Infused Gummies
- 420 with CNW – Federally Funded Study Disproves Marijuana Legalization Myths
Sharing Services Global Corporation (SHRG)
Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., announces revenues of $35.4 million for its fiscal first quarter ended July 31, 2019, more than double revenues of $12.9 million reported in the comparable quarter of 2018. Also today, NetworkNewsWire released a report on the company detailing how, today SHRG announced execution of a mutually satisfactory settlement agreement with 212 Technologies, LLC concerning related disputes arising out of a series of commercial agreements previously executed between the parties. To view the full press release, visit http://nnw.fm/Vgj5m and http://nnw.fm/4fO8X.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Tuesday's trading session at $0.19, up 33.8028%, on 118,000 volume with 4 trades. The average volume for the last 3 months is 36,083 and the stock's 52-week low/high is $0.090000003/$0.3944.
- Sharing Services Global Corporation (SHRG) Announces Record Q1 Revenues, Cumulative Sales of $129M
- Sharing Services Inc. (SHRG) Announces Mutually Satisfactory Settlement Agreement with 212 Technologies, LLC and Record Q1 Revenues, Cumulative Sales of $129M
- Sharing Services Global Corporation (SHRG) Subsidiary’s Innovative Wellness Products Offer Customers a D.O.S.E. of Happines
Willow Biosciences Inc. (CSE: WLLW)
Willow Biosciences Inc. (CSE: WLLW) was featured today in a publication from CBDWire, examining how Cannabidiol (CBD) has quickly surfaced as one of the most versatile and effective medical treatments around. From simple ailments such as pain and inflammation to severe conditions such as diabetes and epilepsy, CBD has proven to be effective at managing a variety of disorders.
Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.
The company is headquartered in Calgary, Alberta, Canada.
Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.
The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.
Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.
Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.
Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.
The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.
Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.
The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.
The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.
The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.
Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.
President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.
Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.
Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.
Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.
Willow Biosciences Inc. (CSE: WLLW), closed Tuesday's trading session at $0.70, up 1.45%, on 46,804 volume with 17 trades. The average volume for the last 3 months is 92,133 and the stock's 52-week low/high is $0.529999971/$5.25.
- Iowa Parents Struggle to Find Doctors to Recommend Cannabidiol
- New Study Finds Florida Residents Among the Heaviest of CBD Users
- London Event Discusses CBD Regulation and Safety
SRAX Inc. (NASDAQ: SRAX)
SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, this morning announced that the company’s CEO and founder Christopher Miglino will be interviewed by The Wall Street Resource at 8:00 AM PDT on October 17, 2019. To view the full press release, visit http://nnw.fm/ea0PP.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $2.05, off by 2.8436%, on 63,491 volume with 327 trades. The average volume for the last 3 months is 92,650 and the stock's 52-week low/high is $1.54999995/$5.8499999.
- SRAX, Inc. (NASDAQ: SRAX) CEO to be Interviewed by The Wall Street Resource
- SRAX Partners with ZAP, One of the Largest Loyalty Programs in the Philippines, to Integrate Point-of-Sale Data with BIGtoken
- As Tech Data Industry Takes $55 Billion Hit, SRAX Inc. (NASDAQ: SRAX) Sidesteps the Bullet by Doing What’s Right
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
Lithium-focused exploration company Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) today announced completion of transport and current installation of the final modules of its “LiSTR” direct lithium extraction Demonstration Plant at Lanxess’ South Plant facility in southern Arkansas. To view the full press release, visit http://nnw.fm/La8wU.
Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.
The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.
“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”
Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.
LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.
Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.
The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.
Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.
World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.
Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.
Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.
The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.
Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.
Standard Lithium Ltd. (OTC: STLHF), closed Tuesday's trading session at $0.533, up 3.8986%, on 41,164 volume with 17 trades. The average volume for the last 3 months is 29,650 and the stock's 52-week low/high is $0.483999997/$1.20000004.
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Installs Final Modules of “LiSTR” Direct Lithium Extraction Demonstration Plant at Arkansas Project Site
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Announces Delivery of Phases 1 & 2, Begins Installation of Direct Lithium Extraction Demonstration Plant
Sugarmade, Inc. (SGMD)
Sugarmade, Inc. (SGMD) was featured today in a publication from HempWireNews, examining how, in Wisconsin, the state’s Senate passed a bill designed to enable farmers to start growing industrial hemp on a commercial scale. The legislation is supposed to grant the right to control the state’s hemp program to the Department of Agriculture, Trade and Consumer Protection.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.0111, up 5.7143%, on 1,151,879 volume with 43 trades. The average volume for the last 3 months is 4,168,372 and the stock's 52-week low/high is $0.00975/$0.164000004.
- Wisconsin Senate Passes Hemp Bill
- 420 with CNW – 5 Things to Discuss about Medical Marijuana with Your Doctor
- CBD Isn’t the Fabled Elixir of Youth, But It’s a Lot Closer Than You’d Think
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) holds a diversified portfolio of cannabis brands including its wholly owned subsidiary, 7ACRES. To view the full article, visit http://cnw.fm/zG3gw.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $0.729, up 5.5764%, on 563,733 volume with 486 trades. The average volume for the last 3 months is 471,660 and the stock's 52-week low/high is $0.636600017/$1.7888.
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Subsidiary Launches Proprietary Sativa-Dominant Strain
- 420 with CNW – ACLU Sues County in Pennsylvania over Medical Marijuana
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Eyes European Growth
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) produces high-quality, organic medical and recreational adult-use cannabis using organic craft growing principles. To view the full article, visit http://cnw.fm/SWnI9. Also today, the company was featured today in a publication from HempWireNews, examining how, in Wisconsin, the state’s Senate passed a bill designed to enable farmers to start growing industrial hemp on a commercial scale. The legislation is supposed to grant the right to control the state’s hemp program to the Department of Agriculture, Trade and Consumer Protection.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Tuesday's trading session at $0.99, up 10.00%, on 1,447,502 volume with 971 trades. The average volume for the last 3 months is 898,058 and the stock's 52-week low/high is $0.819000005/$4.75.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Applies Organic Craft Growing Principles to Produce Premium Cannabis
- Wisconsin Senate Passes Hemp Bill
- The Psilocybin Mushroom Story Could be the Next Big Investment Boom
Trxade Group Inc. (TRXD)
Pharmaceutical services company Trxade Group Inc. (OTCQB: TRXD)made a favorable impression on The Bowser Report editor Faris Sleem, who noted recently in a MoneyShow report (http://nnw.fm/8u7Eo) that “TRXD is an undiscovered market leader that should continue to capture more market share in the years to come.”
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Tuesday's trading session at $1.10, even for the day, on 3,000 volume with 1 trade. The average volume for the last 3 months is 3,652 and the stock's 52-week low/high is $0.230000004/$1.60000002.
- Trxade Group Inc. (TRXD) Presents Appealing Profile in Recent Pharmaceutical Services Industry Analysis
- Trxade Group Inc. (TRXD) Empowers Small, Independent Pharmacies
- Trxade Group Inc. (TRXD) Equipping Community Pharmacies with the Tools Needed to Overcome Their Biggest Challenges
Xalles Holdings Inc. (OTC: XALL)
Xalles Holdings Inc. (OTC: XALL) was featured today in a publication from CryptoCurrencyWire, examining how many proponents of cryptocurrency are viewing signs of a possible economic recession as the potential foot in the door for a decentralized financial system, such as bitcoin, to take root. The Chinese yuan is plummeting as the U.S. fuels trade war. The European Central Bank is taking desperate measures to support the EU’s struggling economy. All of these aspects and more have given a large number of institutional financial commentators cause for concern over the state of the global economy, as press reports suggest (http://ccw.fm/4Gwyx).
Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.
The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.
Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.
All current subsidiaries are wholly owned
- Xalles Holdings
Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
- Xalles Capital
Management support of investment consortiums, direct investment into funds or projects, and management of investments
- Xalles Limited
Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
- Xalles Technology
Technical development of the X2X blockchain systems
- Xalles Financial Services
Consumer and small business financial service offerings
- Co-Owners Rewards
Stock-based rewards system for payments cards and financial services
- Amazing Living Enterprises
Affiliate program and e-commerce platform for enhancing financial lives
- Global Savings Network
Not-for-profit fundraising system with consumer discounts at local merchants
Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.
Advancements in 2019
- Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
- Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
- Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.
“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”
– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)
Xalles Holdings Inc. (OTC: XALL), closed Tuesday's trading session at $0.0032, up 8.1081%, on 57,556 volume with 4 trades. The average volume for the last 3 months is 2,324,444 and the stock's 52-week low/high is $0.0013/$0.021029999.
- Xalles Holdings Inc. (XALL) Enters Cryptocurrency Distribution Agreement as Fiat Money Faces Bleak Outlook
- Xalles Holdings Inc. (XALL) Targets Growing Global Account-Reconciliation Software Market
- Xalles Holdings Inc. (XALL) Building Fintech Support Strategy Through Acquisitions, Mentoring
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) B2 Social Media Network Surpasses 3.9M Connections in Q2 2019
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Opens Learning Center Featuring Augmented Reality Games, Educational Content
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Featured in Broadcast Discussing California’s Cannabis Industry
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) View from the C-Suite: Narbé Alexandrian, President & Chief Executive Officer, Canopy Rivers Inc., tells his company's story. Filmed on September 24, 2019
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – Marijuana Will be Legalized this Month, Says Mexican Senate Leader
- ChineseInvestors.com (CIIX) Penetrates Asian Markets via Popular Shopping Platform
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Names New CFO; Announces Private Placement, Equity Issuances
- CloudCommerce (OTCQB: CLWD) Employs Behavioral-Science Approach to Identify Custom Audiences
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) Targets Emergent Biotechnology Cannabis Sector
- Endonovo Therapeutics (OTCQB: ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference
- Geyser Brands Inc. (TSX.V: GYSR) University of Wyoming Releases Hemp Publication
- GP Solutions (GWPD) Trading to Recommence October 17, 2019
- Grapefruit Boulevard Investments Inc. (IGNG) Key Requirements for Starting a Successful CBD Brand
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Key Requirements for Starting a Successful CBD Brand
- Green Hygienics Holdings Inc. (GRYN) Hemp Pollen Researchers Get USDA Grant
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Creates Proprietary, Ethanol-Based Distillation System
- INmune Bio, Inc. (NASDAQ: INMB) to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in October
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Reports Milestone Q2 Revenues, Completes Transformational Acquisitions
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Advances Innovation Research Through Agreement with Altria
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Nearly a Thousand Businesses Sign Letter Asking Congress to Deschedule Marijuana
- MustGrow Biologics Corp (CSE: MGRO) Outlines Portfolio of Natural Bio-Pesticides and Bio-Fertility Products
- Neutra Corp. (OTCQB: NTRR) Why the World of Fashion Should Turn to Hemp
- Nightfood, Inc. (OTCQB: NGTF) Announces Distribution in Harris Teeter Supermarkets, Adding Over 250 Stores Throughout the Southeast and Mid-Atlantic Regions
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Why the World of Fashion Should Turn to Hemp
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Opportunity Research Report Issued by Goldman Small Cap Research
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Ability to Employ Clean Oil Recovery Technology
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Partners with John Legend, Casper Sleep for Nationwide Launch of CBD-Infused Gummies
- Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Takes Part in Groundbreaking Genomes Project
- Pressure BioSciences Inc. (PBIO) Proprietary PCT Platform Demonstrates Ability to Discover Cancer Biomarkers in Independent Research
- Quest Patent Research Corp. (QPRC) Committed to Protecting Financial Data System, Takes Apple to Court on Patent Infringement Charges
- Sharing Services Global Corporation (SHRG) Subsidiary’s Innovative Wellness Products Offer Customers a D.O.S.E. of Happines
- SinglePoint, Inc. (SING) Green Light Documentary Predicts CBD Products Will Be Common Like Vitamin Pills
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Leading Taxi Technology Distributor Increases Purchase Order to Over $850,000
- Spectrum Global Solutions, Inc. (SGSI) Set to Capitalize on Rising TELCO CAPEX
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – ACLU Sues County in Pennsylvania over Medical Marijuana
- SRAX Inc. (NASDAQ: SRAX) Partners with ZAP, One of the Largest Loyalty Programs in the Philippines, to Integrate Point-of-Sale Data with BIGtoken
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) 420 with CNW – 5 Things to Discuss about Medical Marijuana with Your Doctor
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 420 with CNW – ACLU Sues County in Pennsylvania over Medical Marijuana
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) The Psilocybin Mushroom Story Could be the Next Big Investment Boom
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Green Light Documentary Predicts CBD Products Will Be Common Like Vitamin Pills
- Trxade Group Inc. (TRXD) Empowers Small, Independent Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans
- VPR Brands, LP (VPRB) Shifting Focus to Rising Star of CBD
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Advancing Toward Global Expansion Goal
- Willow Biosciences Inc. (CSE: WLLW) New Study Finds Florida Residents Among the Heaviest of CBD Users
- Xalles Holdings Inc. (XALL) Targets Growing Global Account-Reconciliation Software Market
- Youngevity International, Inc. (NASDAQ: YGYI) Signs Letter of Intent with BeneYOU, LLC
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.